Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

L-threonate may help prevent balding by blocking a key hair loss factor.

The document's conclusion cannot be provided because the document is not accessible or understandable.

PT-20 did not significantly improve gray hair repigmentation.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

Promising cancer treatments were found, but the manufacturer closed.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Autoimmune reactions may cause both alopecia areata and HAM.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Activating Tgr5 may help treat hair loss and bone loss.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Enhancing Tregs can protect against alopecia areata.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Propylthiouracil treatment can cause hair loss.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Certain gene variations and low adiponectin levels may increase the risk of hair loss in Egyptians.

Anti-androgens can help reduce the effects of male hormones on the skin.